Figure 4.
Regnase-1 limits formation of TPEXCAR-T cells and reduces their memory phenotype. (A) Comparison of TPEX-related gene expression in the presence vs absence of tumor in either WT (left) or KO (right) CAR-T cells. Cutoff FDR < 0.05 or log2FC > 0.5. Data represent biological replicates of 4 to 5 mice per group. (B-E) CD8+ WT and KO CAR-T cells were cotransferred 1:1 into tumor-bearing mice. Organs were harvested 7 and 21 days later. (B) Frequencies of TCF-1+ WT and KO CAR-T cells. (C) Mean fluorescence intensity (MFI) of TOX in TCF-1+ WT and KO CAR-T cells. (D) Frequencies of TCF-1+CD127+KLRG1− and TCF-1+CD127−KLRG1+ WT and KO CAR-T cells. (E) Frequencies of TCF-1+IFNγ+, TCF-1+IL-2+, TCF-1+TNFα+, or TCF-1+granzyme B+ WT and KO CAR-T cells. (F) CD8+ WT and KO CAR-T cells were cotransferred 1:1 into tumor-bearing mice and sorted from spleens 21 days later. Sorted cells (>90% TCF-1+) were cotransferred 1:1 into naive recipients that received hCD19+ B-ALL cells the following day. Spleens were harvested 5 days later. Frequencies of TCF-1+ WT and KO CAR-T cells 21 days after primary tumor stimulation (left) and 5 days after secondary cotransfer and tumor stimulation (right). Data are shown as mean plus or minus SEM and represent 2 independent experiments (B-F; n = 3-5 mice per group). Significance was determined by the paired Student t test (B-F). *P < .05; **P < .01; ***P < .001; ****P < .0001.

Regnase-1 limits formation of TPEXCAR-T cells and reduces their memory phenotype. (A) Comparison of TPEX-related gene expression in the presence vs absence of tumor in either WT (left) or KO (right) CAR-T cells. Cutoff FDR < 0.05 or log2FC > 0.5. Data represent biological replicates of 4 to 5 mice per group. (B-E) CD8+ WT and KO CAR-T cells were cotransferred 1:1 into tumor-bearing mice. Organs were harvested 7 and 21 days later. (B) Frequencies of TCF-1+ WT and KO CAR-T cells. (C) Mean fluorescence intensity (MFI) of TOX in TCF-1+ WT and KO CAR-T cells. (D) Frequencies of TCF-1+CD127+KLRG1 and TCF-1+CD127KLRG1+ WT and KO CAR-T cells. (E) Frequencies of TCF-1+IFNγ+, TCF-1+IL-2+, TCF-1+TNFα+, or TCF-1+granzyme B+ WT and KO CAR-T cells. (F) CD8+ WT and KO CAR-T cells were cotransferred 1:1 into tumor-bearing mice and sorted from spleens 21 days later. Sorted cells (>90% TCF-1+) were cotransferred 1:1 into naive recipients that received hCD19+ B-ALL cells the following day. Spleens were harvested 5 days later. Frequencies of TCF-1+ WT and KO CAR-T cells 21 days after primary tumor stimulation (left) and 5 days after secondary cotransfer and tumor stimulation (right). Data are shown as mean plus or minus SEM and represent 2 independent experiments (B-F; n = 3-5 mice per group). Significance was determined by the paired Student t test (B-F). *P < .05; **P < .01; ***P < .001; ****P < .0001.

Close Modal

or Create an Account

Close Modal
Close Modal